Literature DB >> 17665206

The effect of estrogen on hepatic microcirculation after ischemia/reperfusion.

M Burkhardt1, J E Slotta, P Garcia, A Seekamp, M D Menger, T Pohlemann.   

Abstract

BACKGROUND AND AIMS: Gender dimorphism in clinical manifestation of sepsis, hemorrhage, and trauma is still under investigation. Several experimental studies have indicated a protective effect of estrogen. Nonetheless, the effect of gender on hepatic ischemia/reperfusion remains controversially discussed, and the influence of estrogen is still unclear. In the present study, we investigated whether hepatic ischemia/reperfusion (I/R) injury is gender-dependent and if hepatic microvascular reperfusion injury can be prevented by estrogen.
MATERIALS AND METHODS: Eight female and eight male Sprague-Dawley rats were subjected to 90 min left lobar ischemia followed by 60 min reperfusion. Additional six males were pretreated with 17beta-estradiol 24 h before I/R. Six female and six male rats served as nonischemic sham animals. By means of intravital microscopy, sinusoidal perfusion, leukocyte-endothelial cell interaction, and Kupffer cell activity were analyzed. Finally, arterial blood and liver tissue samples were taken for histomorphological analysis and liver enzyme determination.
RESULTS: After hepatic ischemia/reperfusion, animals revealed a significant gender-specific impairment of hepatic microcirculation, whereas Kupffer cell depression, sinusoidal perfusion failure, leukocyte-endothelial cell interaction within post sinusoidal venules, and parenchymal liver cell damage were more pronounced in male animals. Pretreatment with estrogen caused a normalization of Kupffer cell dysfunction and an amelioration of sinusoidal perfusion failure and venular leukocyte-endothelial cell interaction. However, estrogen did not protect from manifestation of post ischemic parenchymal cell damage.
CONCLUSION: Hepatic ischemia and reperfusion generate a gender-specific occurrence of microvascular injury, which seems to be partially mediated by estrogen. However, additional factors may contribute to the initial post ischemic parenchymal cell damage.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17665206     DOI: 10.1007/s00384-007-0360-5

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  24 in total

1.  The nomenclature of cell death: recommendations of an ad hoc Committee of the Society of Toxicologic Pathologists.

Authors:  S Levin; T J Bucci; S M Cohen; A S Fix; J F Hardisty; E K LeGrand; R R Maronpot; B F Trump
Journal:  Toxicol Pathol       Date:  1999 Jul-Aug       Impact factor: 1.902

Review 2.  Role of microcirculation in hepatic ischemia/reperfusion injury.

Authors:  M D Menger; S Richter; J Yamauchi; B Vollmar
Journal:  Hepatogastroenterology       Date:  1999-06

Review 3.  Current understanding of gender dimorphism in hepatic pathophysiology.

Authors:  Yukihiro Yokoyama; Yuji Nimura; Masato Nagino; Kirby I Bland; Irshad H Chaudry
Journal:  J Surg Res       Date:  2005-09       Impact factor: 2.192

4.  Insight into the mechanism by which estradiol improves organ functions after trauma-hemorrhage.

Authors:  D Jarrar; P Wang; M W Knöferl; J F Kuebler; W G Cioffi; K I Bland; I H Chaudry
Journal:  Surgery       Date:  2000-08       Impact factor: 3.982

5.  Gender differences in hepatic ischemic reperfusion injury in rats are associated with endothelial cell nitric oxide synthase-derived nitric oxide.

Authors:  Ping Lü; Fang Liu; Chun-You Wang; Dao-Da Chen; Zhong Yao; Yuan Tian; Jing-Hui Zhang; Yi-Hua Wu
Journal:  World J Gastroenterol       Date:  2005-06-14       Impact factor: 5.742

6.  The effect of donor gender on graft survival.

Authors:  Martin Zeier; Bernd Döhler; Gerhard Opelz; Eberhard Ritz
Journal:  J Am Soc Nephrol       Date:  2002-10       Impact factor: 10.121

7.  Hepatic microcirculatory perfusion failure is a determinant of liver dysfunction in warm ischemia-reperfusion.

Authors:  B Vollmar; J Glasz; R Leiderer; S Post; M D Menger
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

8.  Impact of leukocyte-endothelial cell interaction in hepatic ischemia-reperfusion injury.

Authors:  B Vollmar; M D Menger; J Glasz; R Leiderer; K Messmer
Journal:  Am J Physiol       Date:  1994-11

9.  Gender of donor influences outcome after orthotopic liver transplantation in adults.

Authors:  D Kahn; J S Gavaler; L Makowka; D H van Thiel
Journal:  Dig Dis Sci       Date:  1993-08       Impact factor: 3.199

Review 10.  Apoptosis, oncosis, and necrosis. An overview of cell death.

Authors:  G Majno; I Joris
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

View more
  5 in total

Review 1.  The effects of estrogen on various organs: therapeutic approach for sepsis, trauma, and reperfusion injury. Part 2: liver, intestine, spleen, and kidney.

Authors:  Takashi Kawasaki; Irshad H Chaudry
Journal:  J Anesth       Date:  2012-06-23       Impact factor: 2.078

Review 2.  The effect of aging on the cutaneous microvasculature.

Authors:  Itay Bentov; May J Reed
Journal:  Microvasc Res       Date:  2015-04-24       Impact factor: 3.514

3.  Suppression of endothelial P-selectin expression contributes to reduced cell trafficking in females: an effect independent of NO and prostacyclin.

Authors:  Inmaculada C Villar; Ramona S Scotland; Rayomand S Khambata; Melissa Chan; Johan Duchene; Andre L Sampaio; Mauro Perretti; Adrian J Hobbs; Amrita Ahluwalia
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-02-24       Impact factor: 8.311

4.  17beta-estradiol mediated protection against vascular leak after hemorrhagic shock: role of estrogen receptors and apoptotic signaling.

Authors:  Ed W Childs; Binu Tharakan; Felicia A Hunter; W Roy Smythe
Journal:  Shock       Date:  2010-09       Impact factor: 3.454

5.  17-estradiol nanoparticles influence inflammatory response of myocardial infarction possibly through downregulation of miR-302b.

Authors:  Hao Ma; Dong Xu; Fei Liu; Qing Yao
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.